Rheumatoid Arthritis: Advances in Diagnosis, Treatment and Prognosis in Clinical Medicine
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".
Deadline for manuscript submissions: 20 November 2025 | Viewed by 569
Special Issue Editors
Interests: rheumatoid arthritis; systemic sclerosis; interstitial lung disease; hereditary angioedema
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to our Special Issue entitled “Rheumatoid Arthritis: Advances in Diagnosis, Treatment and Prognosis in Clinical Medicine”.
Rheumatoid arthritis (RA) is a systemic autoimmune disease that can lead to a high rate of disability. In addition to affecting the joints, RA can involve the lungs, as well as other internal organs, the nervous system, skin, and sensory organs. A well-known association between RA and accelerated atherosclerosis increases the risk of myocardial infarction and stroke. Rheumatoid arthritis is also linked to diastolic dysfunction and other cardiovascular morbidities. The anemia of chronic disease, osteoporosis, depression, and amyloidosis are additional clinical aspects associated with untreated rheumatoid arthritis.
This Special Issue focuses on the clinical aspects of RA, its systemic manifestations, and the application of new diagnostic and therapeutic methods.
Dr. Marko Barešić
Guest Editor
Dr. Joško Mitrović
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatoid arthritis
- pulmonary manifestations of rheumatoid arthritis
- cardiovascular manifestations of rheumatoid arthritis
- rheumatoid arthritis and osteoporosis
- anemia and rheumatoid arthritis
- Felty syndrome
- depression and rheumatoid arthritis
- amyloidosis and rheumatoid arthritis
- rheumatoid arthritis and malignancies
- rheumatoid arthritis and pregnancy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.